Testing effectiveness (Phase 2)Looking for participantsNCT06849167
What this trial is testing
Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC
Who this might be right for
Non-Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 63